Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.

Ryne Biotechnology

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders. The company provides off-the-shelf neuron replacement medicines as effective disease-modifying treatments for neurological disorders, providing doctors with techniques to treat diseases like Parkinson's.

Biotechnology Companies

Medical Organizations

Health Care Companies

Pharmaceutical Companies

Jeffrey Kordower

Carter Cliff

Saisei Ventures

California Institute for Regenerative Medicine

Research institute in California, United States

Alaska Permanent Fund

Permanent fund of oil revenues managed by the State of Alaska

Cure Ventures

Column Group

Venture capital firm for biotechnology companies

Euclidean Capital

Investment firm for individual & family services

San Diego

City in San Diego County, California, United States; second-largest city in California

United States of America

Country primarily located in North America

California

San Diego County

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Nursing and Residential Care Facilities

Pharmaceutical Preparation Manufacturing

Pharmaceutical and Medicine Manufacturing

Chemical Manufacturing

Manufacturing

Health Care and Social Assistance

Health Care and Social Assistance, Health

Kenai Therapeutics

Cellular Dynamics International

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Pharmaceutical Preparations

Drugs

Chemicals And Allied Products

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Offices And Clinics Of Other Health Practitioners

Health Services

Biotechnology company advancing off-the-shelf neuron replacement therapies

Ryne Biotechnology Funding & Investors

Total Amount Raised: $89,000,000

Ryne Biotechnology Funding Rounds

Seed Investors

Series A Investors

Grant Investors

💸 Investors

📚 Popular Blog Posts